- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Niiki Pharma Inc.
Total 2357 results
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedMelanomaUnited States, Canada
-
Astellas Pharma IncWithdrawnAspergillosis/Blood | Aspergillosis/InvasiveUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of YM178United States
-
Astellas Pharma IncCompletedHeart Transplantation | Lung Transplantation | Pancreas (Including SPK) TransplantationFrance, United Kingdom, Taiwan, Belgium, Italy, Austria
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia | Renal DialysisJapan
-
Astellas Pharma IncCompletedA Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal DialysisRenal Insufficiency | Chronic Kidney Disease | Renal DialysisJapan
-
Zurex Pharma, Inc.CompletedSurgical Site InfectionUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDermatitis, AtopicUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDermatitis, AtopicFrance, United Kingdom, Spain, Belgium, Portugal, Netherlands, Finland, Czech Republic, Germany, Hungary, Italy
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedKidney TransplantationPoland, Czech Republic, Hungary, Slovakia
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDermatitis, AtopicUnited Kingdom, Finland, Ireland, Canada, Latvia
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedKidney TransplantationBelgium, France, Germany, Spain, Australia, Italy, Austria, Romania, United Kingdom, Poland, Hungary, Sweden, Netherlands, Czech Republic
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedAspergillosisUnited States
-
Astellas Pharma IncCompletedSleep Initiation and Maintenance DisordersJapan
-
Astellas Pharma IncCompletedSleep Initiation and Maintenance Disorders | Sleep DisordersJapan
-
Astellas Pharma IncCompletedProstate CancerBelgium, France, Spain, Italy, Hungary, Russian Federation, Germany, Slovakia, Finland, Czech Republic
-
Astellas Pharma IncCompletedFunctional DyspepsiaUnited States
-
Akros Pharma Inc.CompletedAnemia in Chronic Kidney DiseaseUnited States
-
Astellas Pharma IncCompletedIntraocular PressureUnited States
-
Astellas Pharma IncCompletedLiver TransplantationUnited States
-
Astellas Pharma IncCompletedLiver TransplantationUnited States
-
Astellas Pharma IncCompletedHealthy SubjectsUnited States
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacodynamics of MirabegronFrance
-
Astellas Pharma IncCompletedPharmacokinetics of YM178United States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedHealthy Subjects | Bioavailability | Pharmacokinetics of MirabegronNetherlands
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP7991Japan
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of Darexaban and MetabolitesFrance
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic InteractionFrance
-
Astellas Pharma IncCompletedArthroplasty, Replacement, KneeUnited States, Canada
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic InteractionFrance
-
Astellas Pharma IncCompletedRheumatoid ArthritisUnited Kingdom, Belgium, Spain, Netherlands, Ireland, Hungary
-
Astellas Pharma IncCompletedChronic Pelvic Pain Syndrome | Chronic Abacterial ProstatitisCzech Republic, Germany, Latvia, Lithuania, Poland, Spain
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedSafety of ASP2151United States
-
Akros Pharma Inc.TerminatedType II Diabetes MellitusUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Astellas Pharma IncCompletedCoronary Artery Disease | Pulmonary Disease, Chronic Obstructive | AsthmaUnited States
-
ZARS Pharma Inc.Terminated
-
ZARS Pharma Inc.Completed
-
ZARS Pharma Inc.CompletedPain | Osteoarthritis, KneeUnited States
-
ZARS Pharma Inc.CompletedMyofascial Pain SyndromesUnited States